Src/ErbB2 induces Akt activation and gemcitabine resistance in pancreatic cancer through amplification cycles [44,45], and apoptosis induced by the caspase signaling pathway is related to the MAPK pathway. The gene discussed is AKT1; the disease is pancreatic neoplasm.